#Sustiva

The tablet contains the same combo as Symfi Lo (efavirenz/lamivudine/tenofovir disoproxil fumarate) but with a higher dose of efavirenz.

This finding comes from an analysis of the global START study, which proved in 2015 that starting HIV treatment early is best.

Highlights from HIV and hepatitis C research presented at the 2018 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston

After a gay man tested HIV positive, a test of his hair indicated he’d adhered well to PrEP—but did he contract a drug-resistant strain?

Investigators behind the recent study that raised this concern suggest not combining the two until more research can be done.

But that is not necessarily the case for those with preexisting mental health problems.

The high proportion of individuals starting treatment with drug resistance already warrants changing the recommended first-line therapy.

Women taking various forms of hormonal contraceptives can likely combine them safely with antiretrovirals.

Clinicians have presented a pair of case reports of patients going on the HIV medication and experiencing severe mental health reactions.

The company is losing its exclusive rights to two HIV drugs: Reyataz and Sustiva.

Such generic drugs could save nations huge sums in the coming years.

Sustiva (efavirenz), which is included in Atripla, is the one antiretroviral that may not combine well with hormonal contraceptives.

Sustiva (efavirenz), which is included in Atripla, is associated with central nervous system side effects and sleep disturbances.

A major randomized, double-blind study pitted Livalo (pitavastatin) against Pravachol (pravastatin).

The switch doesn’t appear to compromise the efficacy of antiretroviral treatment.